[NBY] YoY Annual Result on 31-Dec-2023 [#FY]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
29-Mar-2024
Financial Year
2023
Quarter
31-Dec-2023 [#FY]
Profit Trend
YoY- 40.73%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 14,726 14,404 8,421 9,934 6,599 12,508 18,230 -3.49%
PBT -9,640 -10,608 -5,824 -11,034 -9,652 -6,541 -7,400 4.50%
Tax 35 -3,809 -4,615 5 6 4 3 50.57%
NP -9,640 -16,265 -6,559 -11,039 -10,487 -6,545 -7,403 4.49%
Tax Rate - - - - - - - -
Total Cost 24,366 30,669 14,980 20,973 17,086 19,053 25,633 -0.84%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -65.46 -112.92 -77.89 -111.12 -158.92 -52.33 -40.61 8.27%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -138.65 -353.59 -184.09 -385.53 -593.63 -473.83 -591.81 -21.47%
EPS Diluted -80.05 -353.59 -184.09 -385.53 -593.63 -564.17 -591.81 -28.34%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.